186 related articles for article (PubMed ID: 34638901)
1. Mechanisms Involved in the Promoting Activity of Fibroblasts in HTLV-1-Mediated Lymphomagenesis: Insights into the Plasticity of Lymphomatous Cells.
Rigotto G; Montini B; Mattiolo A; Lazzari N; Piano MA; Remondini D; Marmiroli S; Bertacchini J; Chieco-Bianchi L; Calabrò ML
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638901
[TBL] [Abstract][Full Text] [Related]
2. A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.
Vicario M; Mattiolo A; Montini B; Piano MA; Cavallari I; Amadori A; Chieco-Bianchi L; Calabrò ML
Front Microbiol; 2018; 9():1215. PubMed ID: 29951044
[TBL] [Abstract][Full Text] [Related]
3. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
[TBL] [Abstract][Full Text] [Related]
4. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
Liu Y; Dole K; Stanley JR; Richard V; Rosol TJ; Ratner L; Lairmore M; Feuer G
Leuk Res; 2002 Jun; 26(6):561-7. PubMed ID: 12007504
[TBL] [Abstract][Full Text] [Related]
5. In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer.
Huang TH; Wu ATH; Cheng TS; Lin KT; Lai CJ; Hsieh HW; Chang PM; Wu CW; Huang CF; Chen KY
J Cell Mol Med; 2019 Dec; 23(12):8184-8195. PubMed ID: 31638335
[TBL] [Abstract][Full Text] [Related]
6. Osteolytic bone resorption in adult T-cell leukemia/lymphoma.
Shu ST; Martin CK; Thudi NK; Dirksen WP; Rosol TJ
Leuk Lymphoma; 2010 Apr; 51(4):702-14. PubMed ID: 20214446
[TBL] [Abstract][Full Text] [Related]
7. Adult T-cell leukemia/lymphoma development in HTLV-1-infected humanized SCID mice.
Banerjee P; Tripp A; Lairmore MD; Crawford L; Sieburg M; Ramos JC; Harrington W; Beilke MA; Feuer G
Blood; 2010 Apr; 115(13):2640-8. PubMed ID: 20124219
[TBL] [Abstract][Full Text] [Related]
8. Identification of membrane antigen C33 recognized by monoclonal antibodies inhibitory to human T-cell leukemia virus type 1 (HTLV-1)-induced syncytium formation: altered glycosylation of C33 antigen in HTLV-1-positive T cells.
Fukudome K; Furuse M; Imai T; Nishimura M; Takagi S; Hinuma Y; Yoshie O
J Virol; 1992 Mar; 66(3):1394-401. PubMed ID: 1738199
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma.
Houssein M; Fatfat M; Habli Z; Ghazal N; Moodad S; Khalife H; Khalil M; Gali-Muhtasib H
Life Sci; 2020 Jun; 251():117639. PubMed ID: 32272181
[TBL] [Abstract][Full Text] [Related]
10. B591, a novel specific pan-PI3K inhibitor, preferentially targets cancer stem cells.
Zhou H; Yu C; Kong L; Xu X; Yan J; Li Y; An T; Gong L; Gong Y; Zhu H; Zhang H; Yang X; Li Y
Oncogene; 2019 May; 38(18):3371-3386. PubMed ID: 30635656
[TBL] [Abstract][Full Text] [Related]
11. Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity.
Yasuda K; Torigoe T; Mariya T; Asano T; Kuroda T; Matsuzaki J; Ikeda K; Yamauchi M; Emori M; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N
Lab Invest; 2014 Dec; 94(12):1355-69. PubMed ID: 25329002
[TBL] [Abstract][Full Text] [Related]
12. PI3K/AKT inhibition reverses R-CHOP resistance by destabilizing SOX2 in diffuse large B cell lymphoma.
Chen J; Ge X; Zhang W; Ding P; Du Y; Wang Q; Li L; Fang L; Sun Y; Zhang P; Zhou Y; Zhang L; Lv X; Li L; Zhang X; Zhang Q; Xue K; Gu H; Lei Q; Wong J; Hu W
Theranostics; 2020; 10(7):3151-3163. PubMed ID: 32194860
[TBL] [Abstract][Full Text] [Related]
13. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.
Ishikawa C; Senba M; Mori N
Invest New Drugs; 2021 Apr; 39(2):317-329. PubMed ID: 32959166
[TBL] [Abstract][Full Text] [Related]
14.
Bhattacharya A; Mukherjee S; Khan P; Banerjee S; Dutta A; Banerjee N; Sengupta D; Basak U; Chakraborty S; Dutta A; Chattopadhyay S; Jana K; Sarkar DK; Chatterjee S; Das T
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082288
[TBL] [Abstract][Full Text] [Related]
15. Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.
Tomita M; Semenza GL; Michiels C; Matsuda T; Uchihara JN; Okudaira T; Tanaka Y; Taira N; Ohshiro K; Mori N
Biochem J; 2007 Sep; 406(2):317-23. PubMed ID: 17576198
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.
Kinpara S; Hasegawa A; Utsunomiya A; Nishitsuji H; Furukawa H; Masuda T; Kannagi M
J Virol; 2009 May; 83(10):5101-8. PubMed ID: 19264779
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CDKN1A in adult T-cell leukemia/lymphoma despite overexpression of CDKN1A in human T-lymphotropic virus 1-infected cell lines.
Watanabe M; Nakahata S; Hamasaki M; Saito Y; Kawano Y; Hidaka T; Yamashita K; Umeki K; Taki T; Taniwaki M; Okayama A; Morishita K
J Virol; 2010 Jul; 84(14):6966-77. PubMed ID: 20444901
[TBL] [Abstract][Full Text] [Related]
18. Chronic TGF-β exposure drives stabilized EMT, tumor stemness, and cancer drug resistance with vulnerability to bitopic mTOR inhibition.
Katsuno Y; Meyer DS; Zhang Z; Shokat KM; Akhurst RJ; Miyazono K; Derynck R
Sci Signal; 2019 Feb; 12(570):. PubMed ID: 30808819
[TBL] [Abstract][Full Text] [Related]
19. Human T-cell leukaemia/lymphoma virus type 1 syncytium formation is regulated in a cell-specific manner by ICAM-1, ICAM-3 and VCAM-1 and can be inhibited by antibodies to integrin beta2 or beta7.
Daenke S; McCracken SA; Booth S
J Gen Virol; 1999 Jun; 80 ( Pt 6)():1429-1436. PubMed ID: 10374960
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding.
Daenke S; Booth S
J Cell Sci; 2000 Jan; 113 ( Pt 1)():37-44. PubMed ID: 10591623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
